BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 25, 2026
Home » Blogs » BioWorld Perspectives » Four Days Later: The De-Evolution of a #2011BIO Attendee

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

Four Days Later: The De-Evolution of a #2011BIO Attendee

June 30, 2011
By Jennifer Boggs

Assistant Managing Editor

This year marked my fifth BIO International Convention since joining the BioWorld team. I love the BIO meeting. It’s a great way to learn about new trends in the industry, discover potential sources for future BioWorld stories and finally put a lot of faces to names of people I’ve only talked to over the phone. Plus, the parties are fun. But it is a completely crazy schedule. And every year, I’ve found myself moving from different levels of alertness and exhaustion over the four-day period, though I admit a lot of is my own fault for trying to do too much. Here’s my typical BIO progression: Day One: I’m awake before the alarm goes off. I get to the convention center early, so I can orient myself, figure out where all my meetings and sessions are. I’ve got an ambitious schedule, but that’s OK. I feel good. Sharp. The ideas are flowing, and I go all day through the welcome reception without much of a break. Day Two: It takes me a little longer to get going this morning. But I’m still feeling good. I hit all the sessions and interviews on my schedule, write my stories for BioWorld Today and still have a couple of hours to traipse through the massive exhibit hall. Day Three: I hit the snooze button four times. My feet hurt – perhaps that exhibit hall expedition the day before was not such a great idea. But I persevere. Despite my tiredness, I keep up with the schedule, mostly. I make it to the sessions and continue taking notes, though some of my notes don’t make any sense when I read over them later. “Campy potential hobbits biotech,” my notes from one session say. I have no clue what that means. By late afternoon, I start suffering a few temporary fugue states, and my brain starts flashing images of the down comforter and pillow from my hotel room, and I think wistfully how nice it would be to curl up for a few hours of sleep. Instead, I go out for another late night. Day Four: It’s a blur. Somehow I get lost on my way to the press room. I start alternating between punchy and stuporous. At one point, I nearly start cackling like a loon because I realize I’ve forgotten how to spell “protein.” Shouldn’t it be “i” before “e”? Isn’t that the rule? Huh? Spellcheck says “protein.” That just looks weird, though. What a strange word. Protein. You’ve got your pro, you’ve got your tein. Protein, protein, protein. By the time the conference winds down, I’m approaching zombie territory. And I’m not the only one. There are a lot of zombies walking around on the last day. We bob our heads at each other and say our goodbyes in our new zombie language – it’s kind of a monosyllabic sort of speech – and mechanically hand over the last of our business cards. Then we head home to recover. Yep. Good times. I can’t wait do to it again in Boston next year!

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Brain and DNA

    Sangamo presents primate data for prion suppressor ST-506

    BioWorld Science
    Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
  • TREM2 agonists detailed in Pfizer patent

    BioWorld Science
    Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
  • Red dart and target against blue sky

    Unmasking the X: EPAC2 shifts the fragile X landscape

    BioWorld
    Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
  • Skin irritation on hands

    Recludix presents STAT1/3 inhibitors for dermatological diseases

    BioWorld Science
    Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing